Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
immunotherapy
5
×
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
opdivo
pfizer
amgen
bristol-myers squibb
esmo
european society for medical oncology
fda
glaxosmithkline
keytruda
merck
mirati therapeutics
What
cancer
5
×
annual
bio
clinical
conference
esmo
european
medical
oncology
society
abbvie’s
ahead
alzheimer's
approved
ash
bad
barcelona
biofourmis
brain
breast
bucks
cancer's
case
celebrate
chance
combo
companies
corner
data
dating
day
days
december's
disease
doses
drug
failed
fight
fortune
forward
Language
unset
Current search:
biotech
×
cancer
×
immunotherapy
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
